Evaluating exercise testing in patients with Peripheral Artery Disease
Sensitivity and Specificity of the AHA Post-exercise ABI Criteria
This study is trying to see how exercise testing can help understand the challenges faced by people with Peripheral Artery Disease (PAD).
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 5000 (estimated) |
| Ages | 18 Months and up |
| Sex | All |
| Sponsor | Rennes University Hospital Academic / other |
| Locations | 1 site (Rennes) |
| Trial ID | NCT03186391 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the effectiveness of exercise testing in patients suspected of having Peripheral Artery Disease (PAD). It is a non-interventional, prospective, cross-sectional study conducted at a single center, where data from patients referred to the vascular unit for exercise testing will be collected and analyzed. The study focuses on understanding exercise limitations in these patients to improve diagnostic and treatment approaches.
Who should consider this trial
Good fit: Ideal candidates for this study are patients who are referred to a vascular unit for evaluation of exercise limitations related to Peripheral Artery Disease.
Not a fit: Patients who are unable to walk on a treadmill or have severe cardiac conditions that contraindicate stress testing will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the diagnostic accuracy and management strategies for patients with Peripheral Artery Disease.
How similar studies have performed: While this study is observational and focuses on exercise testing, similar approaches in evaluating exercise limitations in PAD have shown promise in improving patient outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients addressed in our vascular unit for exercise limitation Exclusion Criteria: * Incapacity to walk on the treadmill. * A severe cardiopathy contraindicating a stress test
Where this trial is running
Rennes
- Centre hospitalier Universitaire — Rennes, France (Recruiting)
Study contacts
- Principal investigator: Mahé Guillaume, MD-PhD — Rennes University Hospital
- Study coordinator: Mahé Guillaume, MD-PhD
- Email: guillaume.mahe@chu-rennes.fr
- Phone: 2 99 28 42 61
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.